comparemela.com

Latest Breaking News On - New drug targets - Page 1 : comparemela.com

Sporos BioDiscovery to Present Preclinical Findings on SPR1, a Next-Generation TEAD Inhibitor, at th

HOUSTON (BUSINESS WIRE) Sporos BioDiscovery, Inc. (a wholly owned affiliate of Sporos Bioventures, LLC. “Sporos” or the “Company”), a precision oncology company developing a diversified pipeline of small molecule therapeutic programs targeting cancer vulnerabilities in the tumor and tumor microenvironment, today a.

United-states
American
Stephen-rubino
Sporos-biodiscovery
American-association-for-cancer-research
Sporos-bioventures
Sporos-biodiscovery-inc
American-association
Cancer-research
Annual-meeting
Sporo-chief-executive
Molecular-therapeutics

vimarsana © 2020. All Rights Reserved.